Heart failure in patients with atrial fibrillation: Insights from Polish part of the EORP‐AF general long‐term registry

Aims This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF). Methods and results We analysed data from Polish participants of the EURObservational Research Programme‐AF General Long‐Term Registry. The primary endpoint was all‐cau...

Full description

Saved in:
Bibliographic Details
Published in:ESC Heart Failure 2023-02, Vol.10 (1), p.637-649
Main Authors: Budnik, Monika, Gawałko, Monika, Lodziński, Piotr, Tymińska, Agata, Ozierański, Krzysztof, Grabowski, Marcin, Peller, Michał, Wancerz, Anna, Kiliszek, Marek, Opolski, Grzegorz, Lenarczyk, Radosław, Kalarus, Zbigniew, Lip, Gregory Y.H., Balsam, Paweł
Format: Article
Language:English
Subjects:
Atrial fibrillation
Atrial Fibrillation - complications
Cardiac arrhythmia
Cardiology
Cardiomyopathy
Cardiovascular disease
Diabetes
Heart Failure
Heart rate
Hospitalization
Humans
Hypertension
Mid‐range ejection fraction
Missing data
Normal distribution
Original
Peptides
Poland
Preserved ejection fraction
Prognosis
Reduced ejection fraction
Registries
Stroke Volume
Thromboembolism
Variables
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims This study aimed to determine the impact of heart failure (HF) on clinical outcomes in patients with atrial fibrillation (AF). Methods and results We analysed data from Polish participants of the EURObservational Research Programme‐AF General Long‐Term Registry. The primary endpoint was all‐cause death, and the secondary endpoints included hospital readmissions, cardiovascular (CV) interventions, thromboembolic and haemorrhagic events, rhythm control interventions, and other CV or non‐CV diseases development during one‐year follow up. Overall, 688 patients with available data on HF were included into analysis; 51% (n = 351) had HF; of these 48% (n = 168) had reduced ejection fraction (HFrEF), 22% (n = 77) mid‐range EF (HFmrEF), and 30% (n = 106) preserved EF (HFpEF). Compared with patients without HF, those with HF had higher mortality rate (aHR 5.61; 95% CI 1.94–16.22, P 
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.14130